These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 16888913)
21. Detection of the ETV6-NTRK3 chimeric RNA of infantile fibrosarcoma/cellular congenital mesoblastic nephroma in paraffin-embedded tissue: application to challenging pediatric renal stromal tumors. Argani P; Fritsch M; Kadkol SS; Schuster A; Beckwith JB; Perlman EJ Mod Pathol; 2000 Jan; 13(1):29-36. PubMed ID: 10658907 [TBL] [Abstract][Full Text] [Related]
22. Non-resectable congenital tumors with the ETV6-NTRK3 gene fusion are highly responsive to chemotherapy. McCahon E; Sorensen PH; Davis JH; Rogers PC; Schultz KR Med Pediatr Oncol; 2003 May; 40(5):288-92. PubMed ID: 12652616 [TBL] [Abstract][Full Text] [Related]
23. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma. Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897 [TBL] [Abstract][Full Text] [Related]
24. Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers. Urano M; Nagao T; Miyabe S; Ishibashi K; Higuchi K; Kuroda M Hum Pathol; 2015 Jan; 46(1):94-103. PubMed ID: 25456394 [TBL] [Abstract][Full Text] [Related]
25. Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland. Bell D; Ferrarotto R; Liang L; Goepfert RP; Li J; Ning J; Broaddus R; Weber RS; El-Naggar AK Virchows Arch; 2020 Feb; 476(2):295-305. PubMed ID: 31423558 [TBL] [Abstract][Full Text] [Related]
26. Secretory breast carcinoma: unique, triple-negative carcinoma with a favorable prognosis and characteristic molecular expression. Vasudev P; Onuma K Arch Pathol Lab Med; 2011 Dec; 135(12):1606-10. PubMed ID: 22129193 [TBL] [Abstract][Full Text] [Related]
27. Fusion of ETV6 with an intronic sequence of the BAZ2A gene in a paediatric pre-B acute lymphoblastic leukaemia with a cryptic chromosome 12 rearrangement. Panagopoulos I; Strömbeck B; Isaksson M; Heldrup J; Olofsson T; Johansson B Br J Haematol; 2006 May; 133(3):270-5. PubMed ID: 16643428 [TBL] [Abstract][Full Text] [Related]
29. Detection of ETV6 and RUNX1 gene rearrangements using fluorescence in situ hybridization in Mexican patients with acute lymphoblastic leukemia: experience at a single institution. Pérez-Vera P; Montero-Ruiz O; Frías S; Ulloa-Avilés V; Cárdenas-Cardós R; Paredes-Aguilera R; Rivera-Luna R; Carnevale A Cancer Genet Cytogenet; 2005 Oct; 162(2):140-5. PubMed ID: 16213362 [TBL] [Abstract][Full Text] [Related]
30. Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q. Orsetti B; Nugoli M; Cervera N; Lasorsa L; Chuchana P; Rougé C; Ursule L; Nguyen C; Bibeau F; Rodriguez C; Theillet C Br J Cancer; 2006 Nov; 95(10):1439-47. PubMed ID: 17060936 [TBL] [Abstract][Full Text] [Related]
31. Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan. Sharif MA; Mamoon N; Mushtaq S; Khadim MT J Coll Physicians Surg Pak; 2009 Feb; 19(2):99-103. PubMed ID: 19208313 [TBL] [Abstract][Full Text] [Related]
32. Molecular detection of the ETV6-NTRK3 gene fusion differentiates congenital fibrosarcoma from other childhood spindle cell tumors. Bourgeois JM; Knezevich SR; Mathers JA; Sorensen PH Am J Surg Pathol; 2000 Jul; 24(7):937-46. PubMed ID: 10895816 [TBL] [Abstract][Full Text] [Related]
33. Correlation of HER-2/neu protein overexpression with other prognostic and predictive factors in invasive ductal breast cancer. Ivkovic-Kapicl T; Knezevic-Usaj S; Djilas-Ivanovic D; Panjkovic M In Vivo; 2007; 21(4):673-8. PubMed ID: 17708365 [TBL] [Abstract][Full Text] [Related]
34. [Analysis and clinical significance of ETV6 rearrangement in myelodysplastic syndromes patients]. Ding BT; Guo NJ; Sun JZ; Gao HM; Wang YS; Chen Y Zhonghua Xue Ye Xue Za Zhi; 2007 Dec; 28(12):804-7. PubMed ID: 18476590 [TBL] [Abstract][Full Text] [Related]
35. Breast infiltrating ductal carcinoma: analysis of hormone, HER-2 receptors and Ki-67 proliferation marker. Mustać E; Zamolo G; Petković M; Dordević G; Radić J; Grgurević E; Batinac T Coll Antropol; 2008 Sep; 32(3):741-6. PubMed ID: 18982746 [TBL] [Abstract][Full Text] [Related]
36. MNX1-ETV6 fusion gene in an acute megakaryoblastic leukemia and expression of the MNX1 gene in leukemia and normal B cell lines. Taketani T; Taki T; Sako M; Ishii T; Yamaguchi S; Hayashi Y Cancer Genet Cytogenet; 2008 Oct; 186(2):115-9. PubMed ID: 18940475 [TBL] [Abstract][Full Text] [Related]
37. Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum. Laé M; Fréneaux P; Sastre-Garau X; Chouchane O; Sigal-Zafrani B; Vincent-Salomon A Mod Pathol; 2009 Feb; 22(2):291-8. PubMed ID: 19011601 [TBL] [Abstract][Full Text] [Related]
38. ETV6-NTRK3 gene fusion in a secretory carcinoma of the breast of a male-to-female transsexual. Grabellus F; Worm K; Willruth A; Schmitz KJ; Otterbach F; Baba HA; Kimmig R; Metz KA Breast; 2005 Feb; 14(1):71-4. PubMed ID: 15695086 [TBL] [Abstract][Full Text] [Related]
39. [Clinicopathologic features of mammary analogue secretory carcinoma of salivary glands]. Zhang XP; Ni H; Wang X; Chen H; Shi SS; Yu B; Zhou XJ; Rao Q Zhonghua Bing Li Xue Za Zhi; 2017 Jan; 46(1):34-37. PubMed ID: 28072974 [No Abstract] [Full Text] [Related]
40. Evaluation of estrogen receptor alpha and beta and progesterone receptor expression and correlation with clinicopathologic factors and proliferative marker Ki-67 in breast cancers. Rosa FE; Caldeira JR; Felipes J; Bertonha FB; Quevedo FC; Domingues MA; Moraes Neto FA; Rogatto SR Hum Pathol; 2008 May; 39(5):720-30. PubMed ID: 18234277 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]